BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 21667135)

  • 1. Frequent development of leptomeningeal carcinomatosis in patients with peritoneal dissemination of gastric cancer.
    Emoto S; Ishigami H; Yamaguchi H; Yamashita H; Kaisaki S; Kitayama J
    Gastric Cancer; 2011 Oct; 14(4):390-5. PubMed ID: 21667135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leptomeningeal carcinomatosis from gastric cancer successfully treated by the intrathecal methotrexate plus temozolomide and simultaneous radiotherapy: Case report and literatures review.
    Liu Y
    Cancer Biol Ther; 2017 Oct; 18(10):761-764. PubMed ID: 28881161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant transformation and subsequent leptomeningeal carcinomatosis of a gastric polyp in a dog.
    Didehvar DS; Lanza MR; Atherton MJ; Lenz JA
    J Vet Intern Med; 2024; 38(3):1744-1750. PubMed ID: 38587203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leptomeningeal Carcinomatosis From Carcinoma of Unknown Primary in a Young Patient: A Case Report and a Literature Review.
    Moosavi L; D'Assumpcao C; Bowen J; Heidari A; Cobos E
    J Investig Med High Impact Case Rep; 2019; 7():2324709619869380. PubMed ID: 31423841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors and outcomes in patients with leptomeningeal melanomatosis.
    Harstad L; Hess KR; Groves MD
    Neuro Oncol; 2008 Dec; 10(6):1010-8. PubMed ID: 18708343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meningeal carcinomatosis with decreased visual acuity: a case report.
    Kuramochi M; Kaji R; Sumi R; Ikura A; Takajo T; Yamaguchi A; Nozaki Y; Hosoda Y
    Clin J Gastroenterol; 2024 Apr; 17(2):211-215. PubMed ID: 38091234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leptomeningeal disease in BRIP1-mutated pancreatic adenocarcinoma.
    Yim E; Leung D
    BMJ Case Rep; 2022 Jun; 15(6):. PubMed ID: 35675963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of cerebrospinal fluid tumor cell count in leptomeningeal disease from solid tumors.
    Barbour AB; Blouw B; Taylor LP; Graber JJ; McGranahan T; Blau M; Halasz LM; Lo SS; Tseng YD; Venur V; Yang JT
    J Neurooncol; 2024 May; 167(3):509-514. PubMed ID: 38441840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of intrathecal chemotherapy in the management of meningeal carcinomatosis in patients with breast cancer.
    Meneguetti RT; Cruz FJSM; Del Giglio A
    Einstein (Sao Paulo); 2023; 21():eAO0481. PubMed ID: 38126659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatal progression of the leptomeningeal carcinomatosis from primary rectal adenocarcinoma: A case report.
    Lee TG; Hwang HJ
    Asian J Surg; 2024 May; 47(5):2328-2330. PubMed ID: 38336490
    [No Abstract]   [Full Text] [Related]  

  • 11. New strategies for the treatment of breast cancer with leptomeningeal metastasis.
    Chew SM; Seidman AD
    Curr Opin Oncol; 2023 Nov; 35(6):500-506. PubMed ID: 37820086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autopsy diagnosis of leptomeningeal carcinomatosis, the first manifestation of gastric adenocarcinoma: a rare case report and review of the literature.
    Geramizadeh B; Fereidooni M; Dehghan A; Bagheri-Lankarani K
    Gastroenterol Hepatol Bed Bench; 2021; 14(3):276-280. PubMed ID: 34221268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leptomeningeal Carcinomatosis: A Rare Presentation of Perforated Gastric Cancer.
    Schwarzova K; Li X; Adekunle F; Gupta A
    Cureus; 2023 Nov; 15(11):e48775. PubMed ID: 38098918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occult Breast Cancer Presenting as Leptomeningeal Carcinomatosis.
    McNally ME; Carson W
    World J Oncol; 2012 Apr; 3(2):73-77. PubMed ID: 29147283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of slow-rate ventriculolumbar perfusion chemotherapy for leptomeningeal carcinomatosis: a phase II study.
    Jang S; Gwak HS; Joo J; Doh YS; Shin SH; Yoo H; Wang KC
    Acta Neurochir (Wien); 2024 Mar; 166(1):117. PubMed ID: 38424255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Breakthroughs in the Diagnosis of Leptomeningeal Carcinomatosis: A Review of Liquid Biopsies of Cerebrospinal Fluid.
    Goldberg M; Mondragon-Soto MG; Altawalbeh G; Meyer B; Aftahy AK
    Cureus; 2024 Feb; 16(2):e55187. PubMed ID: 38558729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel approaches to treatment of leptomeningeal metastases.
    Primdahl D; Cohen-Nowak A; Kumthekar P
    Curr Opin Neurol; 2023 Dec; 36(6):592-602. PubMed ID: 37865856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Unfamiliar Imaging Pattern of Leptomeningeal Metastasis.
    Phuyal S; Sahoo B; Nayak MK
    Neurol India; 2023; 71(6):1328-1329. PubMed ID: 38174505
    [No Abstract]   [Full Text] [Related]  

  • 19. Muscle invasive bladder cancer culminating with leptomeningeal carcinomatosis.
    Swallow TW; Mabbutt S; Bell CR
    Can Urol Assoc J; 2015; 9(11-12):E903-4. PubMed ID: 26834903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medulloblastoma uses GABA transaminase to survive in the cerebrospinal fluid microenvironment and promote leptomeningeal dissemination.
    Martirosian V; Deshpande K; Zhou H; Shen K; Smith K; Northcott P; Lin M; Stepanosyan V; Das D; Remsik J; Isakov D; Boire A; De Feyter H; Hurth K; Li S; Wiemels J; Nakamura B; Shao L; Danilov C; Chen T; Neman J
    Cell Rep; 2021 Jul; 36(4):109475. PubMed ID: 34320362
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.